InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,499.65
(
0.31%
)
US TECH 100
19,298.00
(
0.17%
)
Dow Jones
39,358.49
(
0.50%
)
Brent Oil
85.26
(
-0.19%
)
Bitcoin
61,522.02
(
-0.14%
)
Post# of 252412
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Biowatch

Send PM Follow Ignore
Followers 59
Posts 6639
Boards Moderated 1
Alias Born 10/18/2003

Biowatch

Member Level

Re: DewDiligence post# 20441

Wednesday, 12/14/2005 4:35:03 PM

Wednesday, December 14, 2005 4:35:03 PM

Post# of 252412
>>Amgen to Acquire Abgenix for $22.50 Per Share<<

That's a very hefty premium. They get the manufacturing facilities too, as well as Pani and presumably the technology and IP to create fully human monoclonal antibodies.

Dew, weren't you also one of the ones who thought the Pani data wasn't good enough, or the press release not clear enough?

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up